Suprefort
Khavinson natural peptide complex derived from pancreatic tissue — studied for exocrine and endocrine pancreatic function, digestive enzyme production, and metabolic regulation.
🔬 Mechanism of Action
Suprefort is a Khavinson Cytomax derived from whole pancreatic tissue, containing peptides from both acinar (exocrine) and islet (endocrine) compartments. This dual coverage distinguishes it from Pancragen (KEDW), which specifically targets beta-cell insulin genes.
Suprefort modulates: (1) digestive enzyme synthesis genes including trypsinogen, lipase, and amylase in acinar cells, (2) insulin and glucagon gene expression in islet cells, (3) pancreatic duct bicarbonate secretion for pH regulation, and (4) trypsin inhibitor expression (SPINK1) — the protective mechanism preventing autodigestion.
Suprefort is used for chronic pancreatitis rehabilitation, exocrine insufficiency, and pancreatic support alongside Pancragen for comprehensive metabolic optimization.
Source: PMID: 15677927
📜Background & History
Suprefort is the pancreatic Cytomax extract — natural counterpart to synthetic Pancragen.
🎯 Research Use Cases
- ✓Pancreatic function
- ✓Digestive enzyme support
- ✓Metabolic regulation
💉 Dosing Protocol
| Typical Dose | 1-2 capsules/day |
| Frequency | 1-2× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
⚠️Safety & Considerations
Standard oral Cytomax capsule protocol. Monitor blood glucose in diabetic patients.
⚡Interactions & Contraindications
Monitor blood glucose in diabetic patients.
🔗Synergies & Common Stacks
Suprefort (Cytomax) + Pancragen (synthetic) = layered pancreatic support.